scholarly article | Q13442814 |
P2093 | author name string | Andrew R Marks | |
Gaetano Santulli | |||
Paolo C Colombo | |||
Richard N Kitsis | |||
Alexander Kushnir | |||
Melana Yuzefpolskaya | |||
Steven R Reiken | |||
Ellie Coromilas | |||
Seth I Sokol | |||
Danielle L Brunjes | |||
Sarah J Godfrey | |||
P2860 | cites work | PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts | Q22254160 |
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 | ||
Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle | Q24308714 | ||
The human type 1 inositol 1,4,5-trisphosphate receptor from T lymphocytes. Structure, localization, and tyrosine phosphorylation | Q24313145 | ||
Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias | Q24337832 | ||
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure | Q24530067 | ||
Remodeling of ryanodine receptor complex causes "leaky" channels: a molecular mechanism for decreased exercise capacity | Q24649499 | ||
Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes | Q28116298 | ||
Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias | Q28586317 | ||
Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure | Q30495045 | ||
Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice | Q30497498 | ||
Multiple effects of caffeine on Ca2+ release and influx in human B lymphocytes | Q31857328 | ||
ABC of heart failure. Pathophysiology | Q33817181 | ||
Calcium sparks | Q34014173 | ||
The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling | Q34175375 | ||
Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression | Q34270987 | ||
Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. | Q34312242 | ||
Molecular cloning and characterization of the ryanodine receptor/junctional channel complex cDNA from skeletal muscle sarcoplasmic reticulum | Q34318323 | ||
The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states | Q34420405 | ||
Mitochondrial calcium overload is a key determinant in heart failure. | Q34487198 | ||
Estrogen alters thresholds for B cell apoptosis and activation | Q34792410 | ||
Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices | Q35306045 | ||
Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure. | Q35447198 | ||
Cardiac ryanodine receptor function and regulation in heart disease | Q35807715 | ||
A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation | Q36176549 | ||
PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle: defective regulation in heart failure | Q36325042 | ||
Stressed out: the skeletal muscle ryanodine receptor as a target of stress | Q36407033 | ||
Regulation of calcium channel expression in neonatal myocytes by catecholamines | Q36796737 | ||
Calcium signalling in lymphocyte activation and disease | Q36912139 | ||
Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. | Q36949333 | ||
Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia. | Q37072276 | ||
Impact of Ca2+ signaling on B cell function | Q37945974 | ||
Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application | Q38023611 | ||
Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes | Q39136145 | ||
Plasma norepinephrine in congestive heart failure | Q40127129 | ||
Expression of the ryanodine receptor isoforms in immune cells | Q40773094 | ||
Sodium/calcium exchanger in heart muscle: molecular biology, cellular function, and its special role in excitation-contraction coupling | Q40798143 | ||
Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice | Q41447437 | ||
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein | Q41467443 | ||
Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophy. | Q42149020 | ||
Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. | Q43805158 | ||
beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure | Q43815707 | ||
Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex | Q44094469 | ||
Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol | Q44195414 | ||
Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes | Q44201899 | ||
Protein carbonyl groups as biomarkers of oxidative stress. | Q44317892 | ||
Use of biomarkers in the management of heart failure: are we there yet? | Q44357130 | ||
Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. | Q44438480 | ||
Regulation of the type 1 inositol 1,4,5-trisphosphate receptor by phosphorylation at tyrosine 353. | Q44755165 | ||
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group | Q45116221 | ||
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. | Q45285126 | ||
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association | Q57629814 | ||
G Protein-Coupled Receptor Kinase 2 in Patients With Acute Myocardial Infarction | Q58651682 | ||
Cytosolic calcium staircase in cultured myocardial cells | Q69443116 | ||
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure | Q70376386 | ||
Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation | Q71084759 | ||
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators | Q72267719 | ||
Localization of the high and low affinity [3H]ryanodine binding sites on the skeletal muscle Ca2+ release channel | Q72466225 | ||
Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure | Q73635731 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | biomarker | Q864574 |
P577 | publication date | 2018-03-28 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure. |
Q92353662 | Cardiosomal microRNAs Are Essential in Post-Infarction Myofibroblast Phenoconversion |
Q58699532 | Circulating level of fibroblast growth factor 21 is independently associated with the risks of unstable angina pectoris |
Q96576958 | Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target |
Q89805347 | Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study |
Q90732395 | Panax Notoginseng Saponins Protect Cardiac Myocytes Against Endoplasmic Reticulum Stress and Associated Apoptosis Through Mediation of Intracellular Calcium Homeostasis |
Q96350536 | The role of B cells in heart failure and implications for future immunomodulatory treatment strategies |
Search more.